Novartis AG Registered Shares NOVN.SW 12.05% ...

Novartis' Pluvicto is expected to dominate the market for radioligand therapies for prostate cancer, with ...

TG Therapeutics shares made new 52-week highs this week, helped in part by new Briumvi data presentations at ECTRIMS. Find ...

Earlier switch to atezolizumab after run-in with vemurafenib plus cobimetinib showed promise in improving OS rates in BRAF ...

Most medicines used worldwide are off-patent products – generic or biosimilar versions of branded medicines offering the same quality, safety, and efficacy at a lower price. They are the ‘silent ...

The global supply chain for critical generic medicines faces increasing challenges. The skewed economics of the generic medicines market need to be corrected.